
Met G 2mg/500mg Tablet SR
Marketer
Inavars Biologicals Inc
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Met G 2mg/500mg Tablet SR
Glimepiride/Metformin 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This medication helps regulate blood glucose in diabetic patients. Administer these tablets with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this is part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a readily available fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.
Uses of Met G 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Met G 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met G 2mg/500mg extended-release tablet should be taken with a meal.
Common Side effects of Met G 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Met G 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Met G 2mg/500mg Tablet SR whole; do not crush, chew, or break it. Administer this extended-release tablet with a meal.
How Met G 2mg/500mg Tablet SR works:
The extended-release Met G 2mg/500mg tablet combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Met G 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Met G 2mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against the risks prior to prescribing. Always seek medical advice.
Breast feedingUNSAFE
Extended-release Met G 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Met G 2mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. Met G 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Met G 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Met G 2mg/500mg Tablet SR is typically initiated at a reduced dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Met G 2mg/500mg Tablet SR :
Should you forget a Met G 2mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Met G 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
